DOCSLIB.ORG

FAST TOXICOLOGICAL SCREENING KIT by LC-MS/MS – Code SC9005B

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
FAST TOXICOLOGICAL SCREENING KIT by LC-MS/MS – Code SC9005B FAST TOXICOLOGICAL SCREENING KIT BY LC-MS/MS – Code SC9005B The kit for the toxicological-forensic analysis is a screening method to analyze hundreds of compounds in positive and negative mode, in plasma and blood. It is possible to determine the following molecµles: POSITIVE MODE: Amitrole Alypin Bamifylline 17 -alpha -Methyltestosterone Amantadine Bamipin 2-Amino -5-chlorobenzophenone Ambroxol Beclamide 2-Amino -5-nitrobenzophenone Ambucetamide Beclometasone dipropionate 2-Hydroxyethylflurazepam Amezinium Befunolol 3,4 -Methylenedioxyamphetamine Amidopyrin Bendiocarb 3,4 -Methylenedioxyethylamphetamine Amidotrizoic Acid Benfluorex 3,4 -Methylenedioxymethamphet amine Amiloride Benodanil 3,5 -Diiodotyrosine Aminodantrolene Benperidole 4-Benzamidosalicyclic acid Aminoglutethimide Benproperine 6-Mercaptourine Aminophenazone Bens µl tap 6-O-Monoacetylmorphine Aminopromazine Bentiromide 7-Aminoclonazepam Aminorex Benzatropine 7-Aminodesmethylflunitrazepam Amiodarone Benzocaine 7-Aminoflunitrazepam Amiphenazole Benzoct amine 7-Aminonitrazepam Amis µl pride Benzododecinium 9-Hydroxyrisperidone Amitriptylin Benzoylecgonine cebutolol Amlodipine Benzthiazuron Aceclidine Ammoidin Berberine Aceclofenac Amorolfine Betamethasone 21 -phosphate Acemetacin Amoxicillin Betaxolol Acep romazine Amphetamine Bevonium Aceprometazine Amrinone Bezafibrate Acetiamin Antazoline Biperiden Acetylaminonitroprophoxybenzene Apalcillin Bisoprolol Aciclovir Apomorphine Bornaprine Actinoquinol Apophedrin Brodifacoum Adenine Apraclonidin Bromacil Adrenalone Aprinidine Bromazepam Ajmaline Atenolol Bromocriptine Alachlor Atorvastatin Brompheniramine Alclometasone -17,21 -dipropionate Atraton Brotizolam Alimemazine Atrazine -desethyl Bucetin Alizapride Atropine Bufe xamac Allopurinol Atropinmethylbromid Bumetanide Almitrine Az atadi ne Bunazosin alpha -Hydroxyalprazolam Azelastine Bunitrolol alpha -Hydrox ytriazolam Azintamid Bupivacaine Alprazolam Aztreonam Bupranolol Alprenolol Baclofen Buprenorphine Altretamine Bambuterol Buprofezin 1 Buspirone Clobenzepam Dienogest Butaperazine Clobutino l Diethazine Butetamate Cl omethiazole Diethylcarbamazine Butoxycaine Clomipramine Difenoconazole Cafaminol Clonazepam Difenoxuron Caffeine Clonidine Diflucortolone Candesartan Clopenthixol Dihydrocodeine Caproylresorcinol Clopidogrel Dihydroergocristin Captopril Cloprednol Dihydr oergotamine Carazolol Clozapine Dilazep Carbamazepine Cocaine Diltiazem Carbamazepine 10,11 -ep oxide Codeine Dimetindene Carbendazim Coniine Dimetotiazine Carbinoxamine Corticosterone Dimetridazole Carbutamide Cortisone Dioxethedrin Carbuterol Cotinine Diphenamid Carteolol Coumatetralyl Diphenhydramine Carvedilol Croconazole Diponium Celiprolol Cromoglicic acid Diprophylline Cerivastatin Cyamemazine Dipyridamole Cetirizine Cyclicine Disopyramide Chinine Cyclophosphamide Dixyrazine Chlorazanil Cycl ovalone Dobutamine Chlorbenzoxamine Cyproheptadine Dorzolamide Chlorcyclizine Cytarabine Doxapram Chlordiazepoxide D3 -Doxepin Doxepin Chloridazon D5 -Diazepam Doxylamine Chlormadinone Acetate Dapiprazole Drofenine Chlormequat Deflazacort Dummy Chlorpheneth iazin e Demeton -S-methyls µl fone Ecgoninemethylester Chlorpheniramine Denaverine EDDP Chlorpromazine Desalkylflurazepam Embutramide Chlorpromazine S µl foxide Desipramine Enalapril Chlorprothixene Desmedipham Enoximone Cilastatin Desmethylclobazam Ephedrine Cilazapril Desmethylclomipramine Eprosartan Cimetidine Dexamethasone Esc µl in Cinnarizine Dexamethasone 21 -isonic otina te Esmolol Cinoxacin Dexfenfluramine Estazolam Ciprofloxacin Dextromethorphan Ethenzamide Cisapride Dextropropoxyphene Etofenamate Citalopram Diaveridine Etomidate Clarithromycin Diazepam Etoposide Clemastine Dibutyl adipate Famotidine Clenbuterol Diclofenac Fedrilate Clobazam Dicycloverine Felbamate 2 Felodipine Guanoxan Lisinopril Fenarimol Haloperidol Lonazolac Fendiline Haloxyfop ethoxyethyl ester Loperamide Fenetylline Heptaminol Loratadine Fenflu ramin e Heroin Lorazepam Fenpipramide Hexazinone Lormetazepam Fenpiprane Hexobendine Losartan Fenproporex Histamine Loxapine Fentanyl Histapyrrodine Lysergide Fenticonazole Homatropine Mafenide Fexofenadine Hordenine Mapro tilin e Flecainide Hydrocodone MBDB Flocoumafen Hydrocortisone Mebeverine Floctafenine Hydrocortisone 21 -acetate Meclizine Fluanisone Hydromorphone Meclofenamic acid Fluconazole Hydr oxyzine Mecloxamine Flumazenil Hymecromone Meclozine Flunarizine Imipramine Medazepam Flunitrazepam Indanazoline Mefenamic acid Fluoxetine Indapamine Mefenorex Flupentixol Indinavir Mefexamide Fluphenazine Indoprofen Mefloquine Flupirtine Indoramin Melatonin Flurazepam Iopodic acid Melitracen Flu rochl oridone Ipratropium Meloxicam Fluspirilen Iprazochrome Melperone Fluticasone Propionate Irbesartan Melphalan Fluvastadine Isoaminile Mepindolol Fluvoxamine Isoconazole Mepivacaine Fuberidazole Isoprenaline Meptazinol Furalaxyl Isoproturon Mequitazine Gabapentin Isothipendyl Mescalin e Galantamine Isoxicam Me soridazine Gallopamil Isoxsuprine Mesuximide Gemcitabine Kavain Metaclazepam Glibenclamide Ketamin e Metamfepramone Glibornuride Ke toprofen Metamitron Gliclazide Ketorolac Metamphetamine Glimepiride Ketotifen Metazachlor Glipizide Lamotrigine Metenolone acetate Gliquidone Lercanidipine Metformin Griseof µl vin Levocabastine Methabenzthiazuron Guaifenesin Levodopa Methadone Guan abenz Levomepromazine Methaphenilene Guanethidine Levopropylhexedrin Methapyrilene Guanfacine Lidocaine Methaqualon 3 Methazolamide Nebivolol Oxilofrine Methfuroxam Nefopam Oxitriptan Methocarbamol Nicardipine Oxitropium Methopr otryn e Nicotinamide Oxomemazine Methotrexate Nicotine Oxprenolol Methylephedrine Nifedipine Oxybuprocaine Methylphenidate Nifenazone Oxybutynin Methylscopolamine Niflumic acid Oxyco done Methylthiouracil Nimodipine Oxyfedrine Metipranolol Nimorazole Oxymetazoline Metixene Nisoldipine Oxymorphon Metoprolol N-Isopropylsalicylamide Oxypertine Metronidazole Nitrazepam Papaverine Mets µl furon -methyl Nitrendipine Paracetamol Metyrapone Nizatidi ne Paraoxon Mexiletine N-Methylephedrine Paroxetine Mianserin Nomifensine Penfluridol Miconazole Norbuprenorphine Pentamidine Midazolam Nordiazepam Pentoxyverine Midodrine Nordiazepam N -ethyl Perazine Milrinone Norephedrine Periciazine Minoxidil Norethisterone Perindopril Mirtaz apine Norethisterone acetate Perphenazine Mizolastine Norfenefrine Pethidine Moclobemide Norfentanyl Phenacetin Modafinil Norfloxacin Phenazone Molsidomine Normorphine Phenazopyridine Monocrotophos Nortriptyline Phencyclid ine Monolinuron Noscapine Phenelzine Moperone Nuarimol Pheniramine Morphine Obidoxime Phenprocoumon Morphine -3-ß-D-glucuronide Ofloxacin Phenylephrine Moxaverine Ola nzapi ne Phenyltoloxamine Moxisylyte Ondansetron Phenytoin Moxonidine Opipramol Pholedrine Nabumetone Orciprenaline Physostigmine Nadolol Ornidazole Pilocarpine Naftidrofuryl Orphenadrine Pindolol Naftifine Oxadixyl Pioglitazone Nalidixic acid Oxamyl Pipamperone Nalorphine Oxatomide Pirbuterol Naloxon e Oxazepam Pirenzepine Na ltrexone Oxcarbazepine Piretanide Nandrolone Oxeladin Piritramide Naphazoline Oxetacaine Piroxicam N-Despropylpropafenone Oxiconazole Pizotifen 4 Practolol Risperidone Tetroxoprim Prajmal ium Ritodrine Tetryzoline Pramipexole Rizatriptan THC Prazepam Ropinirole THC -COOH Prazosin Ropivacaine THC -OH Prednisolone Rosiglitazon Thebacon Prednisone Salbutamol Theobromine Prilocaine Salicylamide Theophylline Primaquine Scopolamine Thiabendazole Primidone Serotonin Thiamazole Procainamide Sertindole Thiamine Prochlorperazine Sertraline Thiopr opaza te Procyclidine Sildenafil Thioproperazine Progesterone Simazine Thioridazine Promazine Sotalol Thiram Promethazin Spirapril Tiagabine Prometryn Stano zolol Tiapride Propafenone Sµl fabenzamide Ticlopidine Propiconazole Sµl fadiazine Tiemonium Propionylpromazine Sµl fadoxine Tilidine Propipocaine Sµl faethidole Timolol Propi verine Sµl faguanidine Tinidazole Propranolol Sµl famethizole Tizanidine Propyphenazone Sµl famethoxazole Tocainide Prothiopendyl Sµl fapyridine Tolazoline Protriptyline Sµl faquinoxaline Tolbutamide Pseudoephedrine Sµl indac Toliprolol Psilocin Sµl piride Tolnaftate Pyranocoumarin Sµl tiame Tolpropamine Pyribenzamine Sumatriptan Tolycaine Pyridoxine Suxibuzone Topotecan Pyrimethamine Tadalafil Torasemide Pyritinol Talinolol Tramadol Pyrvinium Tamoxifen Tr anexa mic acid Quetiapine Telmisartan Trazodone Quinapril Temaze pam Triadimenol Quinine Tenocixam Triallate Ramipril Terazosine Triamterene Ranitidine Terbinafine Triazolam Raubasine Terbutaline Trifluperazine Reboxetine Terbutryn Trifluperidol Remox ipride Terconazole Triflupromazine Repaglinide Terfenadine Trimethobenzamide Reproterol Tertalolol Trimethoprim Reserpine Tetracaine Trimipramine Riluzole Tetrazepam Tripelennamine 5 Triprolidine Valdecoxib Xipamide Tritoqualine Valsartan Xylometazoline Tromantadine Vardenafil Yohimbine Tropisetron Venlafaxine Zolpidem Trospium Verapamil Zopiclone Trypta mine Vincamine Zuclopenthixol Tµl obuterol Warfarin Urapidil Xantinol NEGATIVE MODE: Azelaic Acid Ethyl s µl fate 2-Amino -5-nitrobenzophenone Aztreonam Ethyl s µl fate -D5 4-Ben zamidosalicyclic acid Benserazid Furosemid 5-(p -Methylphenyl) -phenylhydantoin Benzthiazide Hydrochlorothiazide 5-Aminosalicylic acid Bezafibrate Morphin -3ßD -glucuronide -D3 6-Mercaptourine Brallobarbital Pentobarbital Acetazolamide Carbenoxolone Phenobarbital Acetylsalicylic Acid Chlorothiazide Propallylonal Adenine Cimetidine THC -COOH Adenosine Cinchonine THC -OH Adrenalone Cortisone Triamcinolone Alprostadil Dinoprost
Load more

Recommended publications
  • Isopropamide Iodide
    www.chemicalland21.com ISOPROPAMIDE IODIDE SYNONYMS (3-Carbamoyl-3,3-diphenylpropyl)diisopropylmethylammonium iodide; 2,2-Diphenyl-4- diisopropylaminobutyramide methiodide; 4-(Diisopropylamino)-2,2-diphenylbutyramide methiodide; gamma-(Aminocarbonyl)-N-methyl-N,N-bis(1-methylethyl)-gamma-phenylbenzenepropanaminium iodide; Iodure d'isopropamide; Ioduro de isopropamida; Isopropamide ioduro; Isopropamidi iodidum; Isoproponum iodide; PRODUCT IDENTIFICATION CAS RN 71-81-8 EINECS RN 200-766-8 FORMULA C23H33IN2O MOL WEIGHT 480.43 PHYSICAL AND CHEMICAL PROPERTIES PHYSICAL STATE white to off-white powder MELTING POINT 199 C BOILING POINT DENSITY SOLUBILITY IN WATER pH VAPOR DENSITY REFRACTIVE INDEX FLASH POINT GENERAL DESCRIPTION Isopropamide is a long-acting anticholinergic and antimuscarinic drug of quaternary ammonium structure. It is used in the form of the iodide, (also bromide or chloride) to treat peptic ulcer and to suppress gastric secretion other gastrointestinal disorders. Brands of Isopropamide drugs: Darbid Dipramide Isamide Marygin-M Piaccamide Priamide Priazimide Sanulcin Tyrimide Quaternary ammonium anticholinergics (Synthetic) ATC Code Product CAS RN. A03AB01 Benzilonium bromide 1050-48-2 A03AB02 Glycopyrrolate 596-51-0 A03AB03 Oxyphenonium 14214-84-7 A03AB04 Penthienate 22064-27-3 A03AB05 Propantheline 50-34-0 A03AB06 Otilonium bromide 26095-59-0 A03AB07 Methantheline 5818-17-7 Please mail us if you want to sell your product or need to buy some products) www.chemicalland21.com ISOPROPAMIDE IODIDE A03AB08 Tridihexethyl 60-49-1 A03AB09 Isopropamide 7492-32-2 A03AB10 Hexocyclium 6004-98-4 A03AB11 Poldine 596-50-9 A03AB12 Mepenzolic acid 25990-43-6 A03AB13 Bevonium 33371-53-8 A03AB14 Pipenzolate 13473-38-6 A03AB15 Diphemanil methylsulfate 62-97-5 A03AB16 (2-Benzhydryloxyethyl)diethyl-methylammonium iodide A03AB17 Tiemonium iodide 144-12-7 A03AB18 Prifinium bromide 4630-95-9 A03AB19 Timepidium bromide 35035-05-3 A03AB21 Fenpiverinium bromide 125-60-0 03AB53 Oxyphenonium, combinations STABILITY AND REACTIVITY STABILITY Stable under normal conditions.
    [Show full text]
  • Management of Chronic Problems
    MANAGEMENT OF CHRONIC PROBLEMS INTERACTIONS BETWEEN ALCOHOL AND DRUGS A. Leary,* T. MacDonald† SUMMARY concerned. Alcohol may alter the effects of the drug; drug In western society alcohol consumption is common as is may change the effects of alcohol; or both may occur. the use of therapeutic drugs. It is not surprising therefore The interaction between alcohol and drug may be that concomitant use of these should occur frequently. The pharmacokinetic, with altered absorption, metabolism or consequences of this combination vary with the dose of elimination of the drug, alcohol or both.2 Alcohol may drug, the amount of alcohol taken, the mode of affect drug pharmacokinetics by altering gastric emptying administration and the pharmacological effects of the drug or liver metabolism. Drugs may affect alcohol kinetics by concerned. Interactions may be pharmacokinetic or altering gastric emptying or inhibiting gastric alcohol pharmacodynamic, and while coincidental use of alcohol dehydrogenase (ADH).3 This may lead to altered tissue may affect the metabolism or action of a drug, a drug may concentrations of one or both agents, with resultant toxicity. equally affect the metabolism or action of alcohol. Alcohol- The results of concomitant use may also be principally drug interactions may differ with acute and chronic alcohol pharmacodynamic, with combined alcohol and drug effects ingestion, particularly where toxicity is due to a metabolite occurring at the receptor level without important changes rather than the parent drug. There is both inter- and intra- in plasma concentration of either. Some interactions have individual variation in the response to concomitant drug both kinetic and dynamic components and, where this is and alcohol use.
    [Show full text]
  • Analysis of Metals in Surface Water Samples
    ENVIRONMENTAL INSTITUTE, s.r.o., Okružná 784/42, 972 41 Koš Annex I Analysis of metals in surface water samples Environmental Institute, s.r.o., Okružná 784/42, 972 41 Koš, Slovakia October 2020 EUWI+, Investigative monitoring of the Dnieper River Basin, October 2020 ENVIRONMENTAL INSTITUTE, s.r.o., Okružná 784/42, 972 41 Koš Surface water samples Cd (ug/L) Pb (ug/L) Hg (ug/L) Ni (ug/L) As (ug/L) Cr (ug/L) Cu (ug/L) Zn (ug/L) Metals – limit values 0.15** 1.2** 0.07*** 4** 24* 9.0* 1.6* 9.6* Table 1: Results of analyses of Sampling point 1 filtered <LOQ <LOQ <LOQ <LOQ 3.38 <LOQ 1.15 4.0 metals in surface water samples. Sampling point 2 filtered 0.547 <LOQ <LOQ 1.845 <LOQ 0.666 1.94 26.5 The values represent dissolved Sampling point 3 filtered <LOQ <LOQ <LOQ <LOQ 1.99 <LOQ 0.89 4.1 concentrations (after filtration of Sampling point 4 filtered <LOQ <LOQ <LOQ 1.33 <LOQ <LOQ 4.21 9.2 the samples). Numbers Sampling point 5 filtered 2.66 <LOQ <LOQ <LOQ <LOQ 2.35 9.39 20.6 highlighted in orange colour Sampling point 6 filtered <LOQ <LOQ <LOQ <LOQ 2.62 <LOQ 4.95 6.9 indicate exceedance of the Sampling point 7 filtered 0.345 <LOQ <LOQ <LOQ <LOQ 0.777 6.06 38.4 toxicity threshold values. Sampling point 8 filtered <LOQ <LOQ <LOQ <LOQ 2.65 <LOQ 1.03 61.7 Sampling point 9 filtered 0.129 <LOQ <LOQ <LOQ 2.29 0.85 5.36 16.4 Sampling point 10 filtered <LOQ <LOQ <LOQ 1.772 <LOQ <LOQ <LOQ 7.9 Sampling point 11 filtered 0.292 <LOQ <LOQ <LOQ <LOQ 1.31 0.82 11.9 Sampling point 12 filtered 0.328 <LOQ <LOQ <LOQ <LOQ 3.89 1.34 2.6 Sampling point 13 filtered <LOQ
    [Show full text]
  • Mechanism of Action of Nicotine in Isolated Urinary Bladder of Guinea-Pig
    Br. J. Pharmacol. (1988), 95, 465-472 Mechanism of action of nicotine in isolated urinary bladder of guinea-pig Tetsuhiro Hisayama, Michiko Shinkai, lIssei Takayanagi & Toshie Toyoda Department of Chemical Pharmacology, Toho University School of Pharmaceutical Sciences, 2-2-1, Miyama, Funabashi, Chiba 274, Japan 1 Nicotine produced a transient contraction of isolated strips of guinea-pig urinary bladder. The response to nicotine was antagonized by the nicotinic receptor antagonist, hexamethonium but was insensitive to tetrodotoxin. 2 The nicotine-induced contraction was potentiated by the cholinesterase inhibitor, physostig- mine, and was reduced to 50% and 70% by the muscarinic cholinoceptor antagonist, atropine and the sympathetic neurone blocking drug, guanethidine, respectively. Chemical denervation with 6- hydroxydopamine abolished the inhibitory effect of guanethidine. Simultaneous treatment with atropine and guanethidine did not abolish the response to nicotine, but the degree of inhibition was comparable to that obtained with atropine alone. 3 The nicotine-induced contraction was insensitive to bunazosin and yohimbine (al- and Cc2-adrenoceptor antagonists, respectively), and exogenously applied noradrenaline did not cause a contraction even in the presence of blockade of noradrenaline uptake mechanisms with desipramine and normetanephrine and of fi-adrenoceptors with propranolol, suggesting a non-adrenergic nature of the sympathomimetic effect of nicotine in this tissue. 4 The nicotine-induced contraction in the presence of atropine was abolished after desensitization of P2-purinoceptors with a, ,B-methylene adenosine 5'-triphosphate, a slowly degradable ATP ana- logue selective for P2-purinoceptors. By this desensitization, the response to ATP, but not to hista- mine, was also abolished. 5 A cyclo-oxygenase inhibitor flurbiprofen partially inhibited the nicotine-induced contraction.
    [Show full text]
  • Customs Tariff - Schedule
    CUSTOMS TARIFF - SCHEDULE 99 - i Chapter 99 SPECIAL CLASSIFICATION PROVISIONS - COMMERCIAL Notes. 1. The provisions of this Chapter are not subject to the rule of specificity in General Interpretative Rule 3 (a). 2. Goods which may be classified under the provisions of Chapter 99, if also eligible for classification under the provisions of Chapter 98, shall be classified in Chapter 98. 3. Goods may be classified under a tariff item in this Chapter and be entitled to the Most-Favoured-Nation Tariff or a preferential tariff rate of customs duty under this Chapter that applies to those goods according to the tariff treatment applicable to their country of origin only after classification under a tariff item in Chapters 1 to 97 has been determined and the conditions of any Chapter 99 provision and any applicable regulations or orders in relation thereto have been met. 4. The words and expressions used in this Chapter have the same meaning as in Chapters 1 to 97. Issued January 1, 2020 99 - 1 CUSTOMS TARIFF - SCHEDULE Tariff Unit of MFN Applicable SS Description of Goods Item Meas. Tariff Preferential Tariffs 9901.00.00 Articles and materials for use in the manufacture or repair of the Free CCCT, LDCT, GPT, UST, following to be employed in commercial fishing or the commercial MT, MUST, CIAT, CT, harvesting of marine plants: CRT, IT, NT, SLT, PT, COLT, JT, PAT, HNT, Artificial bait; KRT, CEUT, UAT, CPTPT: Free Carapace measures; Cordage, fishing lines (including marlines), rope and twine, of a circumference not exceeding 38 mm; Devices for keeping nets open; Fish hooks; Fishing nets and netting; Jiggers; Line floats; Lobster traps; Lures; Marker buoys of any material excluding wood; Net floats; Scallop drag nets; Spat collectors and collector holders; Swivels.
    [Show full text]
  • )&F1y3x PHARMACEUTICAL APPENDIX to THE
    )&f1y3X PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE )&f1y3X PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 3 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. Product CAS No. Product CAS No. ABAMECTIN 65195-55-3 ACTODIGIN 36983-69-4 ABANOQUIL 90402-40-7 ADAFENOXATE 82168-26-1 ABCIXIMAB 143653-53-6 ADAMEXINE 54785-02-3 ABECARNIL 111841-85-1 ADAPALENE 106685-40-9 ABITESARTAN 137882-98-5 ADAPROLOL 101479-70-3 ABLUKAST 96566-25-5 ADATANSERIN 127266-56-2 ABUNIDAZOLE 91017-58-2 ADEFOVIR 106941-25-7 ACADESINE 2627-69-2 ADELMIDROL 1675-66-7 ACAMPROSATE 77337-76-9 ADEMETIONINE 17176-17-9 ACAPRAZINE 55485-20-6 ADENOSINE PHOSPHATE 61-19-8 ACARBOSE 56180-94-0 ADIBENDAN 100510-33-6 ACEBROCHOL 514-50-1 ADICILLIN 525-94-0 ACEBURIC ACID 26976-72-7 ADIMOLOL 78459-19-5 ACEBUTOLOL 37517-30-9 ADINAZOLAM 37115-32-5 ACECAINIDE 32795-44-1 ADIPHENINE 64-95-9 ACECARBROMAL 77-66-7 ADIPIODONE 606-17-7 ACECLIDINE 827-61-2 ADITEREN 56066-19-4 ACECLOFENAC 89796-99-6 ADITOPRIM 56066-63-8 ACEDAPSONE 77-46-3 ADOSOPINE 88124-26-9 ACEDIASULFONE SODIUM 127-60-6 ADOZELESIN 110314-48-2 ACEDOBEN 556-08-1 ADRAFINIL 63547-13-7 ACEFLURANOL 80595-73-9 ADRENALONE
    [Show full text]
  • Wo 2010/075090 A2
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date 1 July 2010 (01.07.2010) WO 2010/075090 A2 (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every C07D 409/14 (2006.01) A61K 31/7028 (2006.01) kind of national protection available): AE, AG, AL, AM, C07D 409/12 (2006.01) A61P 11/06 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, (21) International Application Number: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, PCT/US2009/068073 HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (22) International Filing Date: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 15 December 2009 (15.12.2009) ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (25) Filing Language: English SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, (26) Publication Language: English TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: (84) Designated States (unless otherwise indicated, for every 61/122,478 15 December 2008 (15.12.2008) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, (71) Applicant (for all designated States except US): AUS- ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, PEX PHARMACEUTICALS, INC.
    [Show full text]
  • PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
    Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known.
    [Show full text]
  • WO 2015/072852 Al 21 May 2015 (21.05.2015) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2015/072852 Al 21 May 2015 (21.05.2015) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 36/84 (2006.01) A61K 31/5513 (2006.01) kind of national protection available): AE, AG, AL, AM, A61K 31/045 (2006.01) A61P 31/22 (2006.01) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, A61K 31/522 (2006.01) A61K 45/06 (2006.01) BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (21) International Application Number: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, PCT/NL20 14/050780 KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (22) International Filing Date: MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, 13 November 2014 (13.1 1.2014) PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (25) Filing Language: English TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (26) Publication Language: English (84) Designated States (unless otherwise indicated, for every (30) Priority Data: kind of regional protection available): ARIPO (BW, GH, 61/903,430 13 November 2013 (13. 11.2013) US GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, (71) Applicant: RJG DEVELOPMENTS B.V.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew Et Al
    US009314465B2 (12) United States Patent (10) Patent No.: US 9,314.465 B2 Brew et al. (45) Date of Patent: *Apr. 19, 2016 (54) DRUG COMBINATIONS AND USES IN 2008.0003280 A1 1/2008 Levine et al. ................. 424/456 TREATING A COUGHING CONDITION 2008/O176955 A1 7/2008 Hecket al. 2008, 0220078 A1 9, 2008 Morton et al. (71) Applicant: Infirst Healthcare Limited 2009, O136427 A1 5/2009 Croft et al. 2009, O220594 A1 9, 2009 Field (72) Inventors: John Brew, London (GB); Robin Mark 2012/O128738 A1 5, 2012 Brew et al. Bannister, London (GB) 2012fO252824 A1 10/2012 Brew et al. (73) Assignee: Infirst Healthcare Limited, London FOREIGN PATENT DOCUMENTS (GB) CN 1593451 3, 2005 CN 101024.014 A 8, 2007 (*) Notice: Subject to any disclaimer, the term of this CN 101112383 B 5, 2010 patent is extended or adjusted under 35 DE 4420708 A1 12, 1995 U.S.C. 154(b) by 0 days. EP 2050435 B1 4/2009 GB 2114001 A 8, 1983 This patent is Subject to a terminal dis GB 2284761 A 6, 1995 claimer. GB 2424.185 B 9, 2006 GB 2442828 A 4/2008 JP 62-249924 A 10, 1987 (21) Appl. No.: 14/287,014 JP H1O-316568 A 12/1998 JP 2001-518928 A 10, 2001 (22) Filed: May 24, 2014 JP 200219.3839. A T 2002 JP 2003-012514 A 1, 2003 (65) Prior Publication Data JP 20030552.58 A 2, 2003 JP 2003128549 A 5, 2003 US 2014/O256750 A1 Sep. 11, 2014 JP 2003-321357 A 11, 2003 JP 2005-516917 A 6, 2005 JP 2008O31146 A 2, 2008 Related U.S.
    [Show full text]
  • UNIVERSITE DE NANTES Thomas Gelineau
    UNIVERSITE DE NANTES __________ FACULTE DE MEDECINE __________ Année 2011 N° 139 THESE pour le DIPLÔME D’ÉTAT DE DOCTEUR EN MÉDECINE DES de médecine générale par Thomas Gelineau né le 29 janvier 1983 à Cholet __________ Présentée et soutenue publiquement le 06/12/2011 __________ LE RHUME DE L'ENFANT ET SON TRAITEMENT: DECISION PARTAGEE AVEC LES PARENTS D'APRES UN QUESTIONNAIRE __________ Président : Monsieur le Professeur Olivier MALARD Directeur de thèse : Madame le Professeur Jacqueline LACAILLE 1 Table des matières IIntroduction................................................................................................................ 7 IIDéfinition, état des connaissances...........................................................................8 1Le rhume.......................................................................................................................................8 APhysiopathologie............................................................................................................................. 8 aL'origine virale.................................................................................................................................... 8 bLa saisonnalité................................................................................................................................... 8 cL'âge de survenue.............................................................................................................................. 9 dLe sexe..................................................................................................................................................
    [Show full text]
  • Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Cr
    Drug Name Plate Number Well Location % Inhibition, Screen Axitinib 1 1 20 Gefitinib (ZD1839) 1 2 70 Sorafenib Tosylate 1 3 21 Crizotinib (PF-02341066) 1 4 55 Docetaxel 1 5 98 Anastrozole 1 6 25 Cladribine 1 7 23 Methotrexate 1 8 -187 Letrozole 1 9 65 Entecavir Hydrate 1 10 48 Roxadustat (FG-4592) 1 11 19 Imatinib Mesylate (STI571) 1 12 0 Sunitinib Malate 1 13 34 Vismodegib (GDC-0449) 1 14 64 Paclitaxel 1 15 89 Aprepitant 1 16 94 Decitabine 1 17 -79 Bendamustine HCl 1 18 19 Temozolomide 1 19 -111 Nepafenac 1 20 24 Nintedanib (BIBF 1120) 1 21 -43 Lapatinib (GW-572016) Ditosylate 1 22 88 Temsirolimus (CCI-779, NSC 683864) 1 23 96 Belinostat (PXD101) 1 24 46 Capecitabine 1 25 19 Bicalutamide 1 26 83 Dutasteride 1 27 68 Epirubicin HCl 1 28 -59 Tamoxifen 1 29 30 Rufinamide 1 30 96 Afatinib (BIBW2992) 1 31 -54 Lenalidomide (CC-5013) 1 32 19 Vorinostat (SAHA, MK0683) 1 33 38 Rucaparib (AG-014699,PF-01367338) phosphate1 34 14 Lenvatinib (E7080) 1 35 80 Fulvestrant 1 36 76 Melatonin 1 37 15 Etoposide 1 38 -69 Vincristine sulfate 1 39 61 Posaconazole 1 40 97 Bortezomib (PS-341) 1 41 71 Panobinostat (LBH589) 1 42 41 Entinostat (MS-275) 1 43 26 Cabozantinib (XL184, BMS-907351) 1 44 79 Valproic acid sodium salt (Sodium valproate) 1 45 7 Raltitrexed 1 46 39 Bisoprolol fumarate 1 47 -23 Raloxifene HCl 1 48 97 Agomelatine 1 49 35 Prasugrel 1 50 -24 Bosutinib (SKI-606) 1 51 85 Nilotinib (AMN-107) 1 52 99 Enzastaurin (LY317615) 1 53 -12 Everolimus (RAD001) 1 54 94 Regorafenib (BAY 73-4506) 1 55 24 Thalidomide 1 56 40 Tivozanib (AV-951) 1 57 86 Fludarabine
    [Show full text]